Компания | Кап $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | Дох | Период |
---|---|---|---|---|---|---|---|---|---|---|---|
Passage Bio | 76 | 2023q3 | |||||||||
Madrigal Pharmaceuticals | 4 539 | 2023q1 | |||||||||
Desert Gold Ventures | 10 | 2021 | |||||||||
Xinyuan Real Estate Co | 18 | 2022q2 | |||||||||
Iovance Biotherapeutics | 3 371 | 2023q1 | |||||||||
Karuna Therapeutics | 12 444 | 2023q3 | |||||||||
Ocugen | 371 | 2022 | |||||||||
Atea Pharmaceuticals | 339 | 2023q3 | |||||||||
Sana Biotechnology | 1 804 | 2023q3 | |||||||||
Athira Pharma | 97 | 2023q3 | |||||||||
Vivani Medical | 101 | 2021 | |||||||||
Palo Alto Networks | 88 499 | 2023 | |||||||||
BrainStorm Cell Therapeut... | 21 | 2021 | |||||||||
QuantumScape | 2 585 | 2023q3 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Oric Pharmaceuticals | 759 | 2023q3 | |||||||||
Endo International | 0 | 2023q2 | |||||||||
Aluminum Сorp. of China | 1 879 | 2022 | |||||||||
Greenlane Holdings | 2 | 2023q2 | |||||||||
Baozun | 137 | 2023q3 |